TY  - GEN
AU  - Monge Corella, Susana
AU  - Humphreys, James
AU  - Nicolay, Nathalie
AU  - Braeye, Toon
AU  - Van Evercooren, Izaak
AU  - Holm Hansen, Christian
AU  - Emborg, Hanne-Dorthe
AU  - Sacco, Chiara
AU  - Mateo-Urdiales, Alberto
AU  - Castilla, Jesús
AU  - Martínez-Baz, Iván
AU  - de Gier, Brechje
AU  - Hahné, Susan
AU  - Meijerink, Hinta
AU  - Kristoffersen, Anja Bråthen
AU  - Machado, Ausenda
AU  - Soares, Patricia
AU  - Nardone, Anthony
AU  - Bacci, Sabrina
AU  - Kissling, Esther
AU  - Nunes, Baltazar
AU  - VEBIS-EHR Working Group
PY  - 2024
DO  - 10.1111/irv.13292
UR  - http://hdl.handle.net/20.500.12105/19372
AB  - Using a common protocol across seven countries in the European Union/European Economic Area, we estimated XBB.1.5 monovalent vaccine effectiveness (VE) against COVID-19 hospitalisation and death in booster-eligible ≥ 65-year-olds, during...
LA  - eng
PB  - Wiley
KW  - Cohort design
KW  - COVID-19
KW  - Electronic health records
KW  - Hospitalisation
KW  - Multicountry study
KW  - SARS-CoV-2
KW  - Vaccine effectiveness
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - European Union
KW  - Hospitalization
KW  - SARS-CoV-2
KW  - Vaccine Efficacy
KW  - Humans
KW  - Aged
KW  - Male
TI  - Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study
TY  - research article
ER  -